ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Tampa, FL, USA:

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Tampa, Florida, United States and 7 other locations

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: TAS3681

Phase 1

Taiho Pharma
Taiho Pharma

Tampa, Florida, United States and 33 other locations

or apalutamide) followed by chemohormonal therapy with docetaxel and LHRH analog would improve the outcome of high risk metastatic/stage IV prostate...

Enrolling
Stage IV Prostate Cancer
Prostate Cancer
Drug: New Hormonal Agent
Drug: Luteinizing Hormone Releasing Hormone

Phase 2

H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Tampa, Florida, United States and 107 other locations

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I&T injection for PET/CT imaging in patients with recurrent prostate...

Enrolling
Biochemical Recurrence of Malignant Neoplasm of Prostate
Prostate Adenocarcinoma
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Tampa, Florida, United States and 10 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Sarasota, Florida, United States and 7 other locations

Cu 64 PSMA I&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Tampa, Florida, United States and 8 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Tampa, Florida, United States and 53 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Bay Pines, Florida, United States and 11 other locations

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Enrolling
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

Tampa, Florida, United States and 27 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems